Tag: Rare disease registry GDPR compliance
Comprehensive Guide: Gene Therapy Hospital Readiness, Orphan Drug Exclusivity, GDPR Compliance in Rare Disease Registries, and Rare Hematology Gene Editing
In the rapidly evolving landscape of gene therapy, staying ahead of the curve is crucial for hospitals, pharmaceutical companies, and researchers. As of 2023, over 2000 gene therapies are in development (Nature 2023 Study, SEMrush 2023 Study), making gene therapy hospital readiness, orphan drug exclusivity, GDPR compliance in rare disease registries, and rare hematology gene